Dr Jane R Lagan, MD | |
241 Claremont Avenue, Hometown, PA 18252-4433 | |
(570) 225-7211 | |
(570) 225-7221 |
Full Name | Dr Jane R Lagan |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 241 Claremont Avenue, Hometown, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487654711 | NPI | - | NPPES |
1247479 | Medicaid | PA | |
MD042458L | Other | PA | STATE MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD042458L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jane R Lagan, MD Po Box 1347, Kingston, PA 18704-0347 Ph: (570) 288-8881 | Dr Jane R Lagan, MD 241 Claremont Avenue, Hometown, PA 18252-4433 Ph: (570) 225-7211 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
Rotaviruses are the commonest cause of diarrhea in infants and young children worldwide. To protect against rotavirus infection, in 2013 the Standing Committee on Vaccination in Germany recommended rotavirus vaccination for all infants.
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.
Rheumatoid Arthritis is a chronic disease characterized by joint swelling, pain, and stiffness that affects approximately 1.3 million individuals in the U.S. Unlike the more common osteoarthritis, RA is an autoimmune condition in which the body's immune system mistakenly attacks healthy tissue.
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
› Verified 8 days ago